Overview
Sweden chemical identification firm's Q4 net sales fell over 50% yr/yr
Q4 EBITDA and EBIT were negative, reflecting financial challenges
Company attributes revenue decline to geopolitical factors impacting order intake
Outlook
Serstech expects 2026 gross margin to improve by 10 percentage points compared to 2025
Company aims for average annual sales growth exceeding 30% through 2030
Serstech expects EBITDA margin to surpass 20% in 2027
Result Drivers
GEOPOLITICAL UNCERTAINTY - Threats of new tariffs halted orders, impacting revenue and profitability
IN-HOUSE PRODUCTION - Fully operational in-house production reduces cost of goods sold and eliminates single-source risk
AI INVESTMENT - AI investment enhances product performance, surpassing competitors
Company press release: ID:nGNE9p0qSw
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
SEK 6.38 mln
Q4 EPS
-SEK 0.04
Q4 EBIT
-SEK 10.36 mln
Q4 EBITDA
-SEK 8.26 mln
Analyst Coverage
Wall Street's median 12-month price target for Serstech AB is SEK0.80, about 74.1% above its February 26 closing price of SEK0.46
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)